Stay updated on Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update in the study details or results of a clinical trial related to the efficacy and safety of pembrolizumab compared to standard of care platinum-based chemotherapies in treating participants with previously untreated stage IV, PD-L1 strong expressing Non-Small Cell Lung Cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:21:56.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the required health conditions and prior treatments for inclusion in the study. Previously, this section had no information provided.
    Difference
    34%
    Check dated 2024-05-22T21:10:30.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:17:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.